These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 5080762)

  • 1. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
    Shapiro WR
    Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
    Wheeler GP; Alexander JA
    Cancer Res; 1974 Aug; 34(8):1957-64. PubMed ID: 4842249
    [No Abstract]   [Full Text] [Related]  

  • 3. The uptake of tritiated methotrexate by an experimental glioma.
    Tator CH
    Cancer Res; 1971 Nov; 31(11):1600-5. PubMed ID: 5121663
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on experimental brain tumors.
    Hasegawa H; Shapiro WR; Posner JB; Basler G
    Cancer Res; 1979 Jul; 39(7 Pt 1):2687-90. PubMed ID: 445472
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
    Bray DA; DeVita VT; Adamson RH; Oliverio VT
    Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of trans-1,4-bis-2-dichlorbenzyl-aminoethyl-cyclohexane (AY-9944) on the experimental brain tumor G26A.
    Sirtori CR; Rodriguez GA; Guarino MJ; Azarnoff RS; Boulos BM
    Arzneimittelforschung; 1972 May; 22(5):914-6. PubMed ID: 4626014
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma.
    Zaharko DS; Dedrick RL; Peale AL; Drake JC; Lutz RJ
    J Pharmacol Exp Ther; 1974 Jun; 189(3):585-92. PubMed ID: 4843162
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicology and pharmacology of the nitrosoureas.
    Oliverio VT
    Cancer Chemother Rep 3; 1973 May; 4(3):13-20. PubMed ID: 4201308
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
    Shapiro WR; Ausman JI; Rall DP
    Cancer Res; 1970 Sep; 30(9):2401-13. PubMed ID: 5475484
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy.
    Brereton HD; Bryant TL; Young RC
    Cancer Res; 1975 Sep; 35(9):2420-5. PubMed ID: 1149044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract]   [Full Text] [Related]  

  • 12. Incorporation of pyrimidines and boron analogues into brain tumour and brain tissue of mice. An approach to boron-neutron capture therapy.
    Hatanaka H; Soloway AH; Sweet H
    Neurochirurgia (Stuttg); 1967 May; 10(3):87-95. PubMed ID: 6034264
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitrosourea pharmacodynamics in relation to the central nervous system.
    Walker MD; Hilton J
    Cancer Treat Rep; 1976 Jun; 60(6):725-8. PubMed ID: 954011
    [No Abstract]   [Full Text] [Related]  

  • 14. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical pharmacology of antineoplastic agents (second of two parts).
    Chabner BA; Myers CE; Coleman CN; Johns DG
    N Engl J Med; 1975 May; 292(22):1159-68. PubMed ID: 47611
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood brain barrier for thymidine in experimentally produced tumors of the central nervous system of the rat].
    Citoler P; Drechsler HJ; Thomas C
    Virchows Arch B Cell Pathol; 1971; 7(2):260-2. PubMed ID: 4994380
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations induced by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in deoxyribonucleic acid synthesis in normal and tumorous tissues. Implications for optimal chemotherapy.
    Rosenoff SH; Bostick F; Young RC
    Biochem Pharmacol; 1974 Nov; 23(22):3097-106. PubMed ID: 4441409
    [No Abstract]   [Full Text] [Related]  

  • 18. The uptake, distribution, and antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the murine glioma.
    Levin VA; Shapiro WR; Clancy TP; Oliverio VT
    Cancer Res; 1970 Oct; 30(10):2451-5. PubMed ID: 5474173
    [No Abstract]   [Full Text] [Related]  

  • 19. The chemotherapy of intracerebral vs subcutaneous murine gliomas. A comparative study of the effect of VM 26.
    Shapiro WR
    Arch Neurol; 1974 Mar; 30(3):222-6. PubMed ID: 4812958
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prospects in neuro-oncology].
    Paoletti P; Schiffer D
    Minerva Med; 1984 May; 75(21):1255-7. PubMed ID: 6728273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.